Camille Bedrosian

Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc.

Camille Bedrosian

Camille Bedrosian

Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc.

Overview
RelSci Relationships

1464

Number of Boards

1

Birthday

1953

Age

66

Relationships
RelSci Relationships are individuals Camille Bedrosian likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder & Chairman at Dimension Therapeutics, Inc.

Relationship likelihood: Strong

Founder, President & Chief Executive Officer at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Strong

Chief Business Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Strong

Head, Strategic Orphan Regulatory Affairs at Ovid Therapeutics, Inc.

Relationship likelihood: Strong

Executive Vice President & Chief Financial Officer at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Strong

General Counsel & Executive Vice President at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Strong

Chief Commercial Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Strong

Executive Director at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Strong

Chief Scientific Officer-Ultragenyx Gene Therapy at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Strong

Paths to Camille Bedrosian
Potential Connections via
Relationship Science
You
Camille Bedrosian
Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc.
Education
M.S. Degree in Biophysics

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

MD Degree

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Memberships
Member
Current

The American Society of Hematology 's mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

Member
Current

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology.American Society of Clinical Oncology is the world's leading professional organization representing physicians who treat people with cancer. ASCO's members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

Member
Current

American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC.

Career History
Chief Medical Officer & Executive Vice President
2018 - Current

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.

Chief Medical Officer & Senior Vice President
2008 - 2018

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.

Chief Medical Officer & Vice President
2002 - 2008

ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA.

Boards & Committees
Member, Board of Directors
Prior

Duke Comprehensive Cancer Center develops outpatient bone-marrow transplantation program. The company is headquartered in Durham, NC.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Camille Bedrosian. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Camille Bedrosian's profile does not indicate a business or promotional relationship of any kind between RelSci and Camille Bedrosian.